Losartan Prevents Portal Hypertension-Induced, Redox-Mediated Endothelial Dysfunction in the Mesenteric Artery in Rats

Gastroenterology

Volumn 138, Issue 4, 2010, Pages 1574-1584

  Dal Ros, Stéphanie ^a   Oswald Mammosser, Monique ^b   Pestrikova, Tatiana ^b   Schott, Christa ^a   Boehm, Nelly ^a   Bronner, Christian ^a   Chataigneau, Thierry ^a   Gény, Bernard ^b   Schini Kerth, Valérie B ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Losartan; Oxidative Stress; Portal Hypertension

Indexed keywords

3 NITROTYROSINE; ACETYLCHOLINE; ANGIOTENSIN 1 RECEPTOR; APOCYNIN; CONNEXIN 37; CONNEXIN 40; CONNEXIN 43; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; HYDROETHIDINE; LOSARTAN; NITRIC OXIDE; PEROXYNITRITE; POLYPHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; COMMON BILE DUCT; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; IMMUNOHISTOCHEMISTRY; MALE; MESENTERIC ARTERY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; PULMONARY ARTERY; RAT; RED WINE; WISTAR RAT;

EID: 77950205756     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.10.040     Document Type: Article

References (36)

1. Abraldes J.G., Iwakiri Y., Loureiro-Silva M., et al. Mild increases in portal pressure up-regulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state. Am J Physiol Gastrointest Liver Physiol 290 (2006) G980-G987
2. Nunes H., Lebrec D., Mazmanian M., et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med 164 (2001) 879-885
3. Ling Y., Zhang J., Luo B., et al. The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat. Hepatology 39 (2004) 1593-1602
4. Zhang J., Ling Y., Luo B., et al. Analysis of pulmonary heme and oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology 125 (2003) 1441-1451
5. Sztrymf B., Rabiller A., Nunes H., et al. Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats. Eur Respir J 23 (2004) 752-758
6. Chabot F., Mestiri H., Sabry S., et al. Role of NO in the pulmonary artery hyporeactivity to phenylephrine in experimental biliary cirrhosis. Eur Respir J 9 (1996) 560-564
7. Gómez F.P., Barberà J.A., Roca J., et al. Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology 43 (2006) 1084-1091
8. Brussino L., Bucca C., Morello M., et al. Effect on dyspnoea and hypoxaemia of inhaled N(G)-nitro-L-arginine methyl ester in hepatopulmonary syndrome. Lancet 362 (2003) 43-44
9. Schenk P., Madl C., Rezaie-Majd S., et al. Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med 133 (2000) 701-706
10. Rolla G., Brussino L., Colagrande P., et al. Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation. Ann Intern Med 129 (1998) 375-378
11. Colombato L.A., Albillos A., and Groszmann R.J. The role of central blood volume in the development of sodium retention in portal hypertensive rats. Gastroenterology 110 (1996) 193-198
12. Iwakiri Y., and Groszmann R.J. The hyperdynamic circulation of chronic liver disease: from the patient to the molecule. Hepatology 43 (2006) S121-S131
13. Ming Z., Smyth D.D., and Lautt W.W. Decreases in portal flow trigger a hepatorenal reflex to inhibit renal sodium and water excretion in rats: role of adenosine. Hepatology 35 (2002) 167-175
14. Newby D.E., Wright R.A., Dawson P., et al. The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man. Cardiovasc Res 38 (1998) 485-492
15. Helmy A., Newby D.E., Jalan R., et al. Nitric oxide mediates the reduced vasoconstrictor response to angiotensin II in patients with preascitic cirrhosis. J Hepatol 38 (2003) 44-50
16. Yang Y.Y., Lin H.C., Huang Y.T., et al. Effect of 1-week losartan administration on bile duct-ligated cirrhotic rats with portal hypertension. J Hepatol 36 (2002) 600-606
17. Vercelino R., Tieppo J., Dias A.S., et al. N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome. Basic Clin Pharmacol Toxicol 102 (2008) 370-376
18. Fernando B., Marley R., Holt S., et al. N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat. Hepatology 28 (1998) 689-694
19. Chen M.F., Mo L.R., Lin R.C., et al. Increase of resting levels of superoxide anion in the whole blood of patients with decompensated liver cirrhosis. Free Radic Biol Med 23 (1997) 672-679
20. Rodriguez-Roisin R., Krowka M.J., Hervé P., et al., ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 24 (2004) 861-880
21. Arguedas M.R., Abrams G.A., Krowka M.J., et al. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 37 (2003) 192-197
22. Dal-Ros S., Bronner C., Schott C., et al. Angiotensin II-induced hypertension is associated with a selective inhibition of EDHF-mediated responses in the rat mesenteric artery. J Pharmacol Exp Ther 328 (2009) 478-486
23. Sarr M., Chataigneau M., Martins S., et al. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc Res 71 (2006) 794-802
24. Barrière E., Tazi K.A., Rona J.P., et al. Evidence for an endothelium-derived hyperpolarizing factor in the superior mesenteric artery from rats with cirrhosis. Hepatology 32 (2000) 935-941
25. Carter E.P., Sato K., Morio Y., et al. Inhibition of K(Ca) channels restores blunted hypoxic pulmonary vasoconstriction in rats with cirrhosis. Am J Physiol Lung Cell Mol Physiol 279 (2000) L903-L910
26. Waldron G.J., Ding H., Lovren F., et al. Acetylcholine-induced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase. Br J Pharmacol 128 (1999) 653-658
27. Morio Y., Homma N., Takahashi H., et al. Activity of endothelium-derived hyperpolarizing factor is augmented in monocrotaline-induced pulmonary hypertension of rat lungs. J Vasc Res 44 (2007) 325-335
28. Arguedas M.R., Drake B.B., Kapoor A., et al. Carboxyhemoglobin levels in cirrhotic patients with and without hepatopulmonary syndrome. Gastroenterology 128 (2005) 328-333
29. Gutterman D.D., Miura H., and Liu Y. Redox modulation of vascular tone. Focus of potassium channel mechanisms of dilatation. Arteriscler Thromb Vasc Biol 25 (2005) 671-678
30. Griffith T.M., Chaytor A.T., Bakker L.M., et al. 5-Methyltetrahydrofolate and tetrahydrobiopterin can modulate electrotonically mediated endothelium-dependent vascular relaxation. Proc Natl Acad Sci U S A 102 (2005) 7008-7013
31. Wagatsuma Y., Naritaka Y., Shimakawa T., et al. Clinical usefulness of the angiotensin II receptor antagonist losartan in patients with portal hypertensive gastropathy. Hepatogastroenterology 53 (2006) 171-174
32. De B.K., Bandyopadhyay K., Das T.K., et al. Portal pressure response to losartan compared with propranolol in patients with cirrhosis. Am J Gastroenterol 98 (2003) 1371-1376
33. Heller J., Trebicka J., Shiozawa T., et al. Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis. Liver Int 25 (2005) 657-666
34. Hennington B.S., Zhang H., Miller M.T., et al. Angiotensin II stimulates synthesis of endothelial nitric oxide synthase. Hypertension 31 (1998) 283-288
35. Rajagopalan S., Kurz S., Munzel T., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97 (1996) 1916-1923
36. Kansui Y., Fujii K., Nakamura K., et al. Angiotensin II receptor blockade corrects altered expression of gap junctions in vascular endothelial cells from hypertensive rats. Am J Physiol Heart Circ Physiol 287 (2004) H216-H224